학술논문

Cost-utility analysis and eligibility of dapagliflozin for patients with heart failure across the whole spectrum of ejection fraction
Document Type
Journal
Source
EUROPEAN JOURNAL OF HEART FAILURE; JUL 2023, 25 p197-p197, 1p. Supplement: 2
Subject
Language
English
ISSN
18790844